We are live on ! Find out more
AA

ALPS Advisors Portfolio holdings

AUM $21.3B
1-Year Est. Return 21.71%
This Fund
S&P 500
This Quarter Est. Return
-8.84%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$12.6B
AUM Growth
-$1.88B
Cap. Flow
-$444M
Cap. Flow %
-3.54%
Top 10 Hldgs %
48.35%
Holding
1,050
New
210
Increased
412
Reduced
234
Closed
189

Sector Composition

Rank Sector Weight
1 Energy 56.01%
2 Healthcare 3.42%
3 Financials 3.23%
4 Materials 2.9%
5 Consumer Discretionary 2.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SBSW icon
176
Sibanye-Stillwater
SBSW
$5.92B
$3.18M 0.03%
829,597
+582,450
+236% +$2.52M
AKRX
177
DELISTED
Akorn Inc
AKRX
$3.14M 0.03%
167,999
+29,406
+21% +$797K
TROW icon
178
T. Rowe Price
TROW
$25B
$3.13M 0.02%
28,997
+10,149
+54% +$1.13M
HZNP
179
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.12M 0.02%
219,807
+38,203
+21% +$564K
MINT icon
180
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
$3.1M 0.02%
30,486
+78
+0.3% +$7.92K
BA icon
181
Boeing
BA
$165B
$2.99M 0.02%
9,129
+2,995
+49% +$1.01M
PAGP icon
182
Plains GP Holdings
PAGP
$5.23B
$2.99M 0.02%
137,596
-25,134
-15% -$556K
GBT
183
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.98M 0.02%
61,706
+13,283
+27% +$741K
NG icon
184
NovaGold Resources
NG
$2.6B
$2.96M 0.02%
684,630
+5,140
+0.8% +$20.6K
TXN icon
185
Texas Instruments
TXN
$255B
$2.94M 0.02%
28,340
+9,116
+47% +$987K
PTLA
186
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$2.86M 0.02%
87,516
+15,210
+21% +$667K
IRWD icon
187
Ironwood Pharmaceuticals
IRWD
$611M
$2.8M 0.02%
216,818
+37,682
+21% +$470K
AERI
188
DELISTED
Aerie Pharmaceuticals
AERI
$2.74M 0.02%
50,556
+9,883
+24% +$553K
ENDP
189
DELISTED
Endo International plc
ENDP
$2.72M 0.02%
457,917
+150,078
+49% +$1.05M
ENTA icon
190
Enanta Pharmaceuticals
ENTA
$372M
$2.53M 0.02%
31,263
+10,169
+48% +$783K
CTSH icon
191
Cognizant
CTSH
$21.5B
$2.51M 0.02%
31,155
+11,697
+60% +$925K
SPG icon
192
Simon Property Group
SPG
$74.5B
$2.5M 0.02%
16,199
-320
-2% -$50.9K
FTAI icon
193
FTAI Aviation
FTAI
$22.2B
$2.47M 0.02%
181,622
+14,286
+9% +$211K
BAC icon
194
Bank of America
BAC
$435B
$2.47M 0.02%
82,291
+53,626
+187% +$1.68M
EQIX icon
195
Equinix
EQIX
$107B
$2.46M 0.02%
5,896
+578
+11% +$243K
AIMT
196
DELISTED
Aimmune Therapeutics
AIMT
$2.42M 0.02%
75,900
+19,538
+35% +$688K
PLD icon
197
Prologis
PLD
$138B
$2.39M 0.02%
37,958
+200
+0.5% +$12.4K
HRTX icon
198
Heron Therapeutics
HRTX
$86.3M
$2.38M 0.02%
86,077
+25,679
+43% +$583K
XLRN
199
DELISTED
Acceleron Pharma
XLRN
$2.37M 0.02%
60,670
+10,545
+21% +$448K
MYOK
200
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.34M 0.02%
47,936
+8,332
+21% +$433K

Similar funds

ALPS Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, ALPS Advisors held 1,050 positions worth $12.6B, down 13% from $14.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

ALPS Advisors withdrew a net $444M in Q1 2018, closing 189 positions and reducing 234 holdings. Its most notable exit was Patterson Companies, Inc., an estimated $48.8M position sold in full.

By sector, the portfolio is most concentrated in Energy at 56% of assets, down from 58% a quarter earlier, followed by Healthcare and Financials.

Against the trend, ALPS Advisors opened a new position in Eli Lilly worth $47.3M.

  • ALPS Advisors's largest Q1 2018 buy was Eli Lilly: 611,259 shares worth $47.3M.
  • ALPS Advisors added most to Shell Midstream Partners, L.P. in Q1 2018, an estimated $39.8M increase.
  • ALPS Advisors's biggest Q1 2018 reduction was Energy Transfer Partners, L.P., cutting an estimated $175M.
  • ALPS Advisors fully exited Patterson Companies, Inc. in Q1 2018, selling an estimated $48.8M.
  • ALPS Advisors's ten largest holdings make up 48% of its $12.6B portfolio in Q1 2018.
  • ALPS Advisors opened 210 new positions and closed 189 in Q1 2018.
  • ALPS Advisors's portfolio value fell 13% quarter-over-quarter to $12.6B.

Based on ALPS Advisors's 13F filing for Q1 2018, filed 1 May 2018.